Results 221 to 230 of about 19,801,094 (386)

Composition and Variation of the Human Milk Microbiota Are Influenced by Maternal and Early-Life Factors.

Cell Host and Microbe, 2019
S. Moossavi, S. Sepehri, B. Robertson, L. Bode, S. Goruk, C. Field, L. Lix, R. D. de Souza, A. Becker, P. Mandhane, S. Turvey, P. Subbarao, T. Moraes, D. Lefebvre, M. Sears, E. Khafipour, M. Azad   +16 more
semanticscholar   +1 more source

Early Life Microbiota and Respiratory Tract Infections.

Cell Host and Microbe, 2020
Wouter A. A. de Steenhuijsen Piters, Justyna M. Binkowska, D. Bogaert   +2 more
semanticscholar   +1 more source

Detection of circulating tumor DNA in colorectal cancer patients using a methylation‐specific droplet digital PCR multiplex

Molecular Oncology, EarlyView.
We developed a cost‐effective methylation‐specific droplet digital PCR multiplex assay containing tissue‐conserved and tumor‐specific methylation markers. The assay can detect circulating tumor DNA with high accuracy in patients with localized and metastatic colorectal cancer.
Luisa Matos do Canto, Louise Raunkilde, Jan Lindebjerg, Mads Malik Aagaard, Christina Therkildsen, Jakob Kleif, Lars Henrik Jensen, Torben Frøstrup Hansen, Rikke Fredslund Andersen   +8 more
wiley   +1 more source

Early-Life Events and the Prevalence of Gut-Brain Interaction Disorders in Children. [PDF]

Children (Basel)
Chanpong A, Ponjorn N, Tassanakijpanich N, Koosakulchai V, Rachatawiriyakul P, Kittivisuit S, Khantee P, Laoprasopwattana K.   +7 more
europepmc   +1 more source

The microbiome in early life: implications for health outcomes

Nature Medicine, 2016
S. Tamburini, N. Shen, H. Wu, J. Clemente   +3 more
semanticscholar   +1 more source

Perspectives in educating molecular pathologists on liquid biopsy: Toward integrative, equitable, and decentralized precision oncology

Molecular Oncology, EarlyView.
Liquid biopsy enables minimally invasive, real‐time molecular profiling through analysis of circulating biomarkers in biological fluids. This Perspective highlights the importance of training pathologists through integrative educational programs, such as the European Masters in Molecular Pathology, to ensure effective and equitable implementation of ...
Marius Ilié, Umberto Malapelle, Catherine Alix‐Panabières, Claus Lindbjerg Andersen, Sandra Chlebowski, Vivien Lake, Caroline Lacoux, Virginie Lespinet‐Fabre, Olivier Bordone, Simon Heeke, Christophe Bontoux, Ellen Heitzer, Klaus Pantel, Paul Hofman   +13 more
wiley   +1 more source

Sex effects on early life features of the gingival transcriptome. [PDF]

Front Dent Med
Ebersole JL, Kirakodu SS, Nguyen LM, Gonzalez OA.   +3 more
europepmc   +1 more source

SAT-329 EARLY LIFE FACTORS AND LONGITUDINAL BLOOD PRESSURE TRAJECTORIES ARE ASSOCIATED WITH ELEVATED BLOOD PRESSURE IN EARLY ADULTHOOD: BIRTH TO TWENTY PLUS COHORT [PDF]

, 2019
Sanushka Naidoo, Juliana Kagura, June Fabian, Shane A. Norris, Sara Naicker   +4 more
openalex   +1 more source

Transcriptional network analysis of PTEN‐protein‐deficient prostate tumors reveals robust stromal reprogramming and signs of senescent paracrine communication

Molecular Oncology, EarlyView.
Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice, Jose I. Lopez, Aitziber Ugalde‐Olano, Maite Zufiaurre, Ianire Astobiza, Natalia Martin‐Martin, Laura Bozal‐Basterra, Saioa Garcia‐Longarte, Amaia Zabala‐Letona, Sofia Rey, Aida Santos‐Martin, Miguel Unda, Ana Loizaga‐Iriarte, Mariona Graupera, Paolo Nuciforo, Arkaitz Carracedo, Isabel Mendizabal   +16 more
wiley   +1 more source

Next‐generation proteomics improves lung cancer risk prediction

Molecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj, Clara Frick, Ben Schöttker, Bernd Holleczek, Hermann Brenner   +4 more
wiley   +1 more source